Concepedia

Christopher L. Carpenter

CL

Statistics

Publications

36

Citations

5.5K

H-Index

28

Active since

1993

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Beth Israel Deaconess Hospital

Christopher L. Carpenter is an author at Harvard University specializing in signal transduction, life sciences, and cell signaling.

Publications per year

1993–2021

36

Publications

36

Rac Homologues and Compartmentalized Phosphatidylinositol 4, 5-Bisphosphate Act in a Common Pathway to Regulate Polar Pollen Tube Growth

Benedikt Kost, Emmanuel Lemichez, Pius Spielhofer et al. · The Journal of Cell Biology · 1999 · 567 citations · Full text

, , +17

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 558 citations

, , +12

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

Hongbing Zhang, Gregor Cicchetti, Hiroaki Onda et al. · Journal of Clinical Investigation · 2003 · 497 citations · Full text

, , +17

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

Hongbing Zhang, Gregor Cicchetti, Hiroaki Onda et al. · Journal of Clinical Investigation · 2003 · 479 citations · Full text

, , +17

Rho Family GTPases Bind to Phosphoinositide Kinases

Kimberley F. Tolias, Lewis C. Cantley, Christopher L. Carpenter · Journal of Biological Chemistry · 1995 · 468 citations · Full text

, , +17

1–5 of 36